About
AI Drug Discovery
Areas of Focus
Categories
AI FocusedAustria
Clinical Trials (27)
View allTotal Trials
27
As Lead Sponsor
7
As Collaborator
20
Total Enrollment
5,329
By Phase
NA: 12PHASE4: 4PHASE2: 1
By Status
COMPLETED: 12UNKNOWN: 6RECRUITING: 5ACTIVE_NOT_RECRUITING: 2NOT_YET_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline27 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07213128Collaborator
Effect of IMT in Patients After Acute Exacerbations of COPD
NANot yet recruiting
358 participants
Started: Dec 1, 2025 · Completed: Feb 28, 2029
NCT06523374Collaborator
A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer
NARecruiting
50 participants
Started: Jul 31, 2025 · Completed: Dec 31, 2026
NCT07147140Lead Sponsor
Physiological Parameters in CRPS Patients Treated With Dorsal Root Ganglion Stimulation
NAActive, not recruiting
36 participants
Started: Apr 15, 2025 · Completed: Nov 30, 2025
NCT06356025Lead Sponsor
Botulinum Toxin Injection in the UES for R-CPD
PHASE4Recruiting
30 participants
Started: Sep 2, 2024 · Completed: Jul 31, 2027
NCT06780540Collaborator
Testing and Evaluating a Psychoeducation Tool and Guidelines for Victims of Violence in Belgian Hospitals.
NARecruiting
600 participants
Started: Aug 24, 2024 · Completed: Mar 31, 2025
Locations (1)
Headquarters
Vienna, Austria
Map
Loading map...